["{\n\"step_by_step_thinking\": \"The relevant documents describe the characteristics of patients with schizophrenia, such as their behavior preceding admission to hospital, the effect of marijuana use on their illness, and the adverse effects of neuroleptic agents. The most recent document discusses the clinical development of risperidone, an effective treatment for schizophrenia. Considering these facts, we are asked to identify which adverse effect is increased in this patient. Since risperidone is being initiated as therapy, we should focus on the potential side effects mentioned in the documents. Risperidone's development study mentioned very low rates of extrapyramidal side effects at a dose of about 6 mg daily, but no specific information about agranulocytosis, shortened QT interval, gynecomastia, or weight loss.\",\n\"answer_choice\": \"B\"\n}"]